SLN12140 in Adult Participants With IgA Nephropathy in China
Clinical trial NCT07553494 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07553494
- Sponsor
- Linno Pharmaceuticals, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-29
- Primary completion
- 2027-12-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.